🔗 Share this article

While the US continues making historic changes to its immunization guidelines, an unexpected name has emerged in a surprising turn: Tracy Beth Høeg, a Danish American sports physician and public health researcher who first made her name by questioning coronavirus vaccines during the global health crisis and has zeroed in on potential fatalities following Covid vaccination in her short tenure at the US Food and Drug Administration (FDA).

Planned Overhauls to Pediatric Vaccine Program

Public health authorities were set to announce radical changes to the pediatric immunization program recently, synchronizing the US with the Danish vaccine program, it is understood – a substantial departure that would put the US out of step with a large portion of the world with little proof for benefit. The announcement has been postponed until the coming year.

In place of Vinay Prasad, Høeg is set to speak at the gathering. She was newly appointed acting director of the FDA’s drug evaluation center, the fifth individual to run the division this calendar year.

Consolidating Power at the Regulatory Body

The acting appointment may indicate a tighter collaboration between the pharmaceutical and vaccine divisions as Høeg and Prasad consolidate power at the agency – and it signals a greater focus upon dismantling previously authorized immunizations at the FDA.

The new acting director has repeatedly called for discontinuing specific childhood shot schedules in the US so as to align more like Denmark, a nation with universal health coverage and a citizenry approximately the population of the state of Wisconsin.

To date comments, she has kept her attention on vaccination policy – usually the purview of Dr. Prasad, director of the FDA’s vaccine center – as opposed to drug regulation.

Concerns Over Qualifications

The appointee has no apparent background in pharmaceutical research, regulation or administrative roles, which has been customary for previous directors of the biologics center. She has been employed at the FDA as a senior adviser to the FDA chief and the vaccine center since spring.

“She appears not to have the necessary background” for running the drug-regulation department, stated Jonathan Howard. “She lacks experience running a scientific study. She lacks experience in managing a major agency. She lacks background in drug approvals.”

Former commissioners of the center would “understand legal statutes and the science of drug development”, said Dr. Janet Woodcock. “Clearly, she has not acquired the sort of resume that prior appointees who led the center have had.”

CDER has an enormous portfolio at the agency, Woodcock pointed out.

“Many people just focuses on the novel medication approvals, but the generic program clears numerous generic medications. There’s a biologic copycat branch, non-prescription drug unit and more, and every single one need to be looked after,” Dr. Woodcock explained. “The area you neglect, that is precisely what that I always told people is going to bite you.”

Additionally, a significant leadership element to the role, which oversees in excess of 5,000 personnel. “It is a massive leadership role, if you do it right,” Woodcock added.

Official Statement and Controversial Initiatives

When asked about questions about Høeg’s fitness for the role and whether this assignment signifies more teamwork among agency officials on immunizations, a spokesperson said that the “inquiries are based on inaccurate presumptions”.

“Her resume matches the functions of her position,” the representative stated, citing the months Høeg spent advising the agency head on “pharmaceutical safety and approval science, including computerized risk analysis and immunization monitoring”.

As the temporary head, Høeg takes over the commissioner’s controversial priority voucher program, a contentious expedited medication authorization process that apparently concerned her preceding directors. “How are these drugs being picked for this fast-track system? Who takes the choices?” Howard questioned. “There is a lot of secrecy going on at the FDA right now.”

Broadly speaking, he remarked, “the Food and Drug Administration seems to be moving towards less stringent oversight of all drugs, except for shots.”

Public Track Record on Immunizations

Concerning immunizations, Høeg has a more established, if troubling, past, some experts have noted. She released a research paper using non-validated public submissions to estimate the incidence of heart inflammation following Covid vaccination. She consulted for the Florida top health official Joseph Ladapo, who was said to have altered data to imply Covid vaccinations are more dangerous than they are.

Part of her “wish list” for the current administration included revising guidelines for recently developed shots and ending “optional” vaccines, she said post-election on a online show. At the agency, Dr. Høeg has reportedly proposed preventing adolescent males from receiving COVID-19 vaccinations.

“She’s an all-around true believer who begins with her beliefs and works backwards to fit the science in a highly misleading, untruthful way,” Howard stated.

Consolidating Power and a “Push for Payback”

Høeg joined other skeptics, {like|